Table 1 Clinicopathological characteristics of propensity score matched conventional robot—assisted radical prostatectomy (RARP) and retzius—sparing RARP groups in 51 patients each.
Median (IQR) or n (%) | |||
|---|---|---|---|
Conventional | Retzius—sparing | p-value | |
Number of patients | 51 | 51 | |
Age, y | 67 (63–71) | 67 (64–71) | 0.544 |
BMI | 23.6 (22.3–25.3) | 23.3 (21.4–25.7) | 0.932 |
PSA, ng/ml | 5.8 (5.0–9.4) | 6.8 (5.0–11.9) | 0.795 |
Biopsy GGG | 0.986 | ||
1 | 12 (23%) | 10 (20%) | |
2 | 12 (23%) | 12 (24%) | |
3 | 14 (28%) | 14 (27%) | |
4 | 11 (22%) | 13 (25%) | |
5 | 2 (4%) | 2 (4%) | |
Clinical stage | 1.000 | ||
≦T2 | 48 (94%) | 48 (94%) | |
T3≦ | 3 (6%) | 3 (6%) | |
NADT | 0.695 | ||
No | 48 (84%) | 47 (92%) | |
Yes | 3 (6%) | 4 (8%0 | |
IPSS total score | 9 (5–14) | 8 (4–11) | 0.277 |
IPSS QOL score | 3 (2–4) | 2 (2–3) | 0.586 |
ICIQ-UI SF total score | 0 (0–2) | 0 (0–4) | 0.311 |
Removed prostate size | 40.0 (35.0–45.0) | 36.5 (31.0–48.0) | 0.387 |
Nerve-sparing |  < 0.001 | ||
Non | 3 (6%0 | 19 (37%) | |
Unilateral | 39 (76%) | 30 (59%) | |
Bilateral | 9 (18%) | 2 (4%) | |
Surgical time, Min | 253 (220–279) | 223 (195–253) | 0.018 |
Console time, Min | 181 (162–213) | 158 (137–190) | 0.041 |
Console time except PLND, Min | 169 (144–181) | 158 (137–188) | 0.841 |
PLND |  < 0.001 | ||
Non | 30 (58%) | 48 (94%) | |
Limited | 13 (26%0 | 0 (0%) | |
Exteded | 8 (16%) | 3 (6%) | |
Bleeding (mL) | 100 (50–150) | 175 (100–270) |  < 0.001 |
Blood transfusion, Yes | 0 (0%) | 0 (0%) | 1.000 |
Clavien-Dindo classification | 1.000 | ||
Grade 2 or less | 51 (100%) | 51 (100%) | |
Grade 3 or grater | 0 (0%) | 0 (0%) | |
Catheter indwelling duration | 7 (7–7) | 7 (7–7) | 0.796 |
Positive surgical margin | 8 (16%) | 14 (28%) | 0.149 |
Extraprostatic extension | 9 (18%) | 12 (24%) | 0.463 |
